You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -50.5% | -56.5% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -9.4 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 4.9 | 3.2 |
| Price / Book value | 6.9 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 19.2% | 13.8% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 30.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | 9.29 | -1.45 | $-1.86 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 12.27 | -3.35 | $-0.11 | -15.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 13.98 | -9.92 | $-0.20 | -16.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 16.67 | -8.87 | $-0.17 | -14.2 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 15.77 | -12.08 | -20.19p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 20.96 | -11.85 | -19.70p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 25.12 | -0.37 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| MaxCyte to consolidate stock to single trading line Sharecast News | 21 Feb |
|---|---|
| MaxCyte 'exceptionally positive' following strong FY trading performance Sharecast News | 20 Jan |
| MaxCyte inks new development agreement with KSQ Therapeutics Sharecast News | 04 Dec |
| License Agreement with Allogene Therapeutics | 24-Mar-20 07:04 |
|---|---|
| Consolidation of Trading Lines | 21-Feb-20 07:04 |
| AIM Block Admission Return / Total Voting Rights | 20-Feb-20 18:19 |
| Grant Of Options | 24-Jan-20 16:32 |
| Holding(s) in Company | 22-Jan-20 17:16 |